We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Myriad’s Claims on Genetic Patents Invalidated by Federal Court
Myriad’s Claims on Genetic Patents Invalidated by Federal Court
April 2, 2010
A federal court in New York has ruled that certain claims of patents on Myriad Genetics’ breast and ovarian cancer screening system BRACAnalysis
are invalid, but the ruling is not expected to have a negative effect on the biotechnology industry.